These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 19896336)

  • 1. Prevention of antipsychotic-induced weight gain with early behavioural intervention in first-episode psychosis: 2-year results of a randomized controlled trial.
    Alvarez-Jiménez M; Martínez-García O; Pérez-Iglesias R; Ramírez ML; Vázquez-Barquero JL; Crespo-Facorro B
    Schizophr Res; 2010 Jan; 116(1):16-9. PubMed ID: 19896336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: A randomized controlled trial.
    Alvarez-Jiménez M; González-Blanch C; Vázquez-Barquero JL; Pérez-Iglesias R; Martínez-García O; Pérez-Pardal T; Ramírez-Bonilla ML; Crespo-Facorro B
    J Clin Psychiatry; 2006 Aug; 67(8):1253-60. PubMed ID: 16965204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating an individualized lifestyle and life skills intervention to prevent antipsychotic-induced weight gain in first-episode psychosis.
    Curtis J; Watkins A; Rosenbaum S; Teasdale S; Kalucy M; Samaras K; Ward PB
    Early Interv Psychiatry; 2016 Jun; 10(3):267-76. PubMed ID: 25721464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of adherence to cognitive-behavioural therapy in first-episode psychosis.
    Alvarez-Jiménez M; Gleeson JF; Cotton S; Wade D; Gee D; Pearce T; Crisp K; Spiliotacopoulos D; Newman B; McGorry PD
    Can J Psychiatry; 2009 Oct; 54(10):710-8. PubMed ID: 19835678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nutrition intervention is effective in improving dietary components linked to cardiometabolic risk in youth with first-episode psychosis.
    Teasdale SB; Ward PB; Rosenbaum S; Watkins A; Curtis J; Kalucy M; Samaras K
    Br J Nutr; 2016 Jun; 115(11):1987-93. PubMed ID: 27153205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials.
    Alvarez-Jiménez M; Hetrick SE; González-Blanch C; Gleeson JF; McGorry PD
    Br J Psychiatry; 2008 Aug; 193(2):101-7. PubMed ID: 18669990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.
    Schooler N; Rabinowitz J; Davidson M; Emsley R; Harvey PD; Kopala L; McGorry PD; Van Hove I; Eerdekens M; Swyzen W; De Smedt G;
    Am J Psychiatry; 2005 May; 162(5):947-53. PubMed ID: 15863797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty-Four Week, Randomized, Double-Blind, Placebo-Controlled Trial of Metformin for Antipsychotic-Induced Weight Gain in Patients with First-Episode Psychosis: A Pilot Study.
    Tang C; Chua YC; Abdin E; Subramaniam M; Verma S
    Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study.
    Wu RR; Jin H; Gao K; Twamley EW; Ou JJ; Shao P; Wang J; Guo XF; Davis JM; Chan PK; Zhao JP
    Am J Psychiatry; 2012 Aug; 169(8):813-21. PubMed ID: 22711171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial.
    Wu RR; Zhao JP; Jin H; Shao P; Fang MS; Guo XF; He YQ; Liu YJ; Chen JD; Li LH
    JAMA; 2008 Jan; 299(2):185-93. PubMed ID: 18182600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention.
    Francey SM; Nelson B; Thompson A; Parker AG; Kerr M; Macneil C; Fraser R; Hughes F; Crisp K; Harrigan S; Wood SJ; Berk M; McGorry PD
    Schizophr Res; 2010 Jun; 119(1-3):1-10. PubMed ID: 20347270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted intervention to improve monitoring of antipsychotic-induced weight gain and metabolic disturbance in first episode psychosis.
    Thompson A; Hetrick SE; Alvarez-Jiménez M; Parker AG; Willet M; Hughes F; Gariup M; Gomez DL; McGorry PD
    Aust N Z J Psychiatry; 2011 Sep; 45(9):740-8. PubMed ID: 21827345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive behavioural therapy for weight gain associated with antipsychotic drugs.
    Khazaal Y; Fresard E; Rabia S; Chatton A; Rothen S; Pomini V; Grasset F; Borgeat F; Zullino D
    Schizophr Res; 2007 Mar; 91(1-3):169-77. PubMed ID: 17306507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of lifetime Axis I morbidity among a treated sample of first-episode psychosis patients.
    Bendall S; Allott K; Johnson T; Jackson HJ; Killackey E; Harrigan S; McGorry PD
    Psychopathology; 2008; 41(2):90-5. PubMed ID: 18033978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern of long-term weight and metabolic changes after a first episode of psychosis: Results from a 10-year prospective follow-up of the PAFIP program for early intervention in psychosis cohort.
    Vázquez-Bourgon J; Gómez-Revuelta M; Mayoral-van Son J; Labad J; Ortiz-García de la Foz V; Setién-Suero E; Ayesa-Arriola R; Tordesillas-Gutiérrez D; Juncal-Ruiz M; Crespo-Facorro B
    Eur Psychiatry; 2022 Aug; 65(1):e48. PubMed ID: 35971658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk.
    Morrison AP; French P; Parker S; Roberts M; Stevens H; Bentall RP; Lewis SW
    Schizophr Bull; 2007 May; 33(3):682-7. PubMed ID: 16973786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis.
    Takahashi T; Wood SJ; Yung AR; Soulsby B; McGorry PD; Suzuki M; Kawasaki Y; Phillips LJ; Velakoulis D; Pantelis C
    Arch Gen Psychiatry; 2009 Apr; 66(4):366-76. PubMed ID: 19349306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylenetetrahydrofolate reductase gene variants and antipsychotic-induced weight gain and metabolic disturbances.
    Kao AC; Rojnic Kuzman M; Tiwari AK; Zivkovic MV; Chowdhury NI; Medved V; Kekin I; Zai CC; Lieberman JA; Meltzer HY; Bozina T; Bozina N; Kennedy JL; Sertic J; Müller DJ
    J Psychiatr Res; 2014 Jul; 54():36-42. PubMed ID: 24725652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase-specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial.
    Barrowclough C; Marshall M; Gregg L; Fitzsimmons M; Tomenson B; Warburton J; Lobban F
    Psychol Med; 2014 Oct; 44(13):2749-61. PubMed ID: 25065535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical health assistance in early recovery of psychosis: Study protocol for a randomized controlled trial.
    O'Donoghue B; Mifsud NG; Tindall RM; Foote L; Hartmann JA; Obst K; Simmons MB; McGorry PD; Killackey E
    Early Interv Psychiatry; 2020 Oct; 14(5):587-593. PubMed ID: 31643142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.